Summary Experiments were performed on cultured Chinese hamster ovary cells exposed to haematoporphyrin derivative (HpD) The photosensitizing drug haematoporphyrin derivative (HpD) and light are demonstrating increasing promise in photodynamic therapy (PDT) for cancer (Dougherty, 1984 degenerative changes in mitochondria, ribosomes, endoplasmic reticulum and nuclear chromatin (Kato et al., 1984; Moan et al., 1982) , and inhibits mitochondrial cytochrome c oxidase activity (Gibson & Hill, 1983) . All effects were directly correlated with HpD dose and light exposure level.
The photosensitizing drug haematoporphyrin derivative (HpD) and light are demonstrating increasing promise in photodynamic therapy (PDT) for cancer (Dougherty, 1984) . Unlike most other antineoplastic agents which act on intracellular metabolic and reproductive pathways taking time to kill target cells, photoactivated HpD can kill cells within minutes probably through production of singlet oxygen which lyses the cell membrane (Bellnier & Dougherty, 1982; Weishaupt et al., 1976) .
However, there is growing evidence that HpD plus light may have sublethal effects on other intracellular components in surviving cells. Haematoporphyrin (the less potent parent compound) and HpD plus light have been implicated in induction of sister chromatid exchange and chromosomal aberrations, but not in mutations (Gomer et al., 1983; Evensen & Moan, 1982; Moan et al., 1980) . Cells experienced delay of progression through metaphase after treatment with HpD plus light (Christensen, 1981) , division delay with depression of DNA synthesis (Moan et al., 1983) , and variation in sensitivity through different phases of the cell cycle . Photoactivated HpD has been shown to catalyse the breakdown of polynucleotides (Blazek, 1984 degenerative changes in mitochondria, ribosomes, endoplasmic reticulum and nuclear chromatin (Kato et al., 1984; Moan et al., 1982) , and inhibits mitochondrial cytochrome c oxidase activity (Gibson & Hill, 1983) . All effects were directly correlated with HpD dose and light exposure level.
In the present work, the effect of sublethal doses of photoactivated HpD on DNA and protein synthesis and on progression through the cell cycle have been studied in cultured Chinese hamster ovary (CHO) cells. CHO cells were plated 3-4 days in advance of the experiment to provide stable log phase cultures at the time of exposure to HpD and light. Cells to be assayed on day 0 were plated at 5000 cells per tissue culture flask, decreasing to 500 cells/flask for cells to be assayed on day 6 to avoid confluence.
They were then incubated with 0-60 pgml-1 HpD for 90 min. Cells were exposed to 1140 Jm-2 incandescent light over 10min through the bottom of the tissue culture flasks at 36-38°C on day 0. The cultures were washed once immediately after exposure to HpD and light with Hank's balanced salt solution (HBSS), and then fresh medium was added.
The cells were then assayed on days 0, 1, 2, 3, 4 and 6 for DNA synthesis by addition of 1.0 or with the radioactive labels for 16h, then washed twice with HBSS. After 3h of incubation in fresh nutrient medium, cell viability among attached cells was determined by dye exclusion using trypan blue and visual counting of cells which were or were not stained. Cells were then washed thrice with HBSS. The remaining attached cells were dissolved in 1.0 M sodium hydroxide (NaOH) for 3 h with periodic vortex mixing. Duplicate aliquots of 0.5 ml each were added to 4.5 ml of Biofluor scintillation emulsifier cocktail (New England Nuclear), vortex mixed, and read in a Packard Tricarb liquid scintillation counter. Cellular protein content was measured by absorbances at 260 nm and 280 nm on a Gilford Spectrophotometer 250 by the method of Warburg and Christian (1942 78% reduction in DNA synthesis during the first 16 h (day 0) following exposure to 20 pg ml-1 photoactivated HpD. This inhibition was followed by progressive recovery to the normal rate by day 6. The data suggest a small over-production of DNA during the final phase of recovery on day 4, although this deviation from the normal rate was not statistically significant (P>0.2 by the two-tailed t-test). The same general pattern with reduced deviation from normal was seen for smaller doses of HpD, except that the over-correction occurred on day 3 and full normalization was achieved on day 4. Enhanced DNA synthesis was observed during the first 3 days after 20 pg ml-' HpD in the dark, although this elevation was also not statistically significant (P > 0.05).
Protein synthesis is illustrated in terms of incorporation of radiolabelled amino acids relative to untreated control cultures in Figure 2 . Protein synthesis was somewhat less sensitive dropping initially by 54% after exposure to 20 pgml-l HpD plus light, and fully recovering by day 4. Inhibition of protein synthesis at 5 pg ml-1 HpD was not detectable. Over-correction following inhibition was negligible. Protein synthesis was not affected by HpD alone.
The comparative sensitivity of CHO cells with respect to DNA synthesis, protein synthesis, and cell survival is summarized in Figure 3 . DNA synthesis was clearly the most sensitive to inhibition by photoactivated HpD, followed closely by protein synthesis (dose ratio of 1.2 at the 50% inhibition level). The dose ratio between 50% survival and 50% inhibition of DNA synthesis was 1.9.
Cells in small colonies were exposed to 30 ugml-' HpD plus 1140 Jm-2 light to achieve survival levels of 1-3%. Figure 4 shows solitary surviving cells in a field of otherwise dead cells. Although this cell line has a normal log phase cycle time averaging -15 h, cell division was rarely observed among lone surviving cells until at least 72 h after exposure. No division delay was observed in cells exposed to HpD without light. 
Discussion
The present results corroborate previous studies on NHIK 3025 human carcinoma cells demonstrating that DNA synthesis is the most sensitive to suppression by photoactivated HpD, followed by protein synthesis, and then cell survival (Moan et al., 1983) . Repair of HpD-induced -sublethal damage which cumulatively results in lysis of the cell membrane has been studied using a split-dose technique in human bladder carcinoma cells (Bellnier et al., 1984) . Recovery from division delay was reliably achieved after several generation times with no irreversible loss of proliferative capacity. The evidence collectively demonstrates that cultured mammalian cells can effectively repair and recover from sublethal damage induced by photoactivated HpD.
Primary inhibition of DNA synthesis by sublethal doses of HpD plus light suggests at least partial blockage or delay of the cell cycle in S phase. This could account for division delay as well as reduced where the fluorescence appears more uniformly distributed throughout the cell, we have observed the highest concentration of HpD fluorescence in the nucleolus of rapidly cycling human lymphoblasts derived from a patient with non-Hodgkin's lymphoma ( Figure 5) . This is somewhat different from the nuclear membrane localization of HpD fluorescence observed by Evensen and Moan (1982) in NHIK 3025 cells. It is possible that HpD binds preferentially to nuclear chromatin which is seen electron microscopically to be peripherally distributed in the NHIK 3025 nucleus , but more distributed throughout the nucleus of human lymphoblasts observed above. Nuclear localization of HpD -whether at the nuclear membrane, in chromatin, or at the nucleoluscould account for the greatest sensitivity of DNA synthesis to inhibition. Despite this, photoactivated HpD is much less active in DNA damage and mutation than ionizing radiations at comparable survival levels (Evensen & Moan, 1980; Gomer et al., 1983; Moan et al., 1980) . This emphasizes a critical distinction between reversible inhibition and cellular damage in assessing the effects of HpD treatment.
These results indicate that photoactivated HpD has a wide spectrum of nuclear and cytoplasmic biological activity even at sublethal doses, but full recovery of surviving cells from cyclostasis is reliably achieved after several days. This is consistent with the notion that sublethal effects during clinical PDT are not likely to result in chronic morbidity.
